Cargando…
Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea
BACKGROUND: As the role of immunotherapies and personalized medicine grow, cancer patients have faced many choices in treatments and have suffered financial toxicity. These challenges brought the need for the value framework (VF) to guide treatment decision making. METHODS: A survey was taken to 102...
Autores principales: | Kim, Do Yeun, Ha, Hyerim, Bae, SeungJin, Kang, Jin-Hyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313398/ https://www.ncbi.nlm.nih.gov/pubmed/34313033 http://dx.doi.org/10.3346/jkms.2021.36.e191 |
Ejemplares similares
-
Value Frameworks: Adaptation of Korean Versions of Value Frameworks for Oncology
por: Bae, Green, et al.
Publicado: (2021) -
The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS
por: Ha, Hyerim, et al.
Publicado: (2022) -
Survey of Medical Oncology Status in Korea (SOMOS-K): A National Survey of Medical Oncologists in the Korean Association for Clinical Oncology (KACO)
por: Kim, Do Yeun, et al.
Publicado: (2017) -
The evolving landscape of thoracic surgical oncology
por: Kim, Anthony W., et al.
Publicado: (2023) -
Should oncologists trust cannabinoids?
por: Creanga-Murariu, Ioana, et al.
Publicado: (2023)